Barely Significant

Excerpts

514,629 sentences

highly significantp < 0.0010.0× alphaqualifiedgold
The overall analysis of the NSND group also showed a highly significant association with a high CPS ( p < 0.001). 3.3 Association of Immunohistochemical Expression of PD ‐ L1 , PD ‐1 and Clinicohistopathologic Characteristics The analysis of associations between PD‐L1 and PD‐1 expression with clinical parameters showed a significant association between low PD‐1 expression and advanced T‐stages (T3 + T4) ( p = 0.032), as well as the presence of lymphangiosis carcinomatosa ( p = 0.008).
highly significantP <0.0010.0× alphaqualifiedgold
The following variables that showed a highly significant statistical difference ( P <0.001) in the univariate analyses were entered a stepwise backward logistic regression model: age; Euroscore; preoperative plasma creatinine level; ScO2 minox ; type of surgery; duration of surgery; duration of cardiopulmonary bypass (CPB); lowest hematocrit during CPB; intra- and postoperative use of inotropic/vasoactive agents (noradrenaline, dobutamine, vasopressine); cumulative use of blood products; mean RPP within the first 8 hours after ICU admission, time to first extubation (hours), and reintubation.
nominally significantp<0.0010.0× alphagold
Whereas the treatment difference was nominally significant in IFNGS-high patients (treatment difference: 18.2% (95% CI 10.5 to 25.8); nominal p<0.001), it did not reach nominal significance in IFNGS-low patients (treatment difference: 9.3% (95% CI –8.0 to 26.5) nominal p = 0.292), although the sample size of the IFNGS-low group was small (17.4% of the overall study population) ( figure 1 ; table 1 ).
markedly significantP < .0010.0× alphaqualified
Intraoperative use of 5ALA in patients undergoing surgical resection (ie excluding patients undergoing biopsy alone) was associated with a markedly significant mOS increase from 15.9 weeks (5ALA not used) to 45.4 weeks (5ALA used, Figure 2B ), P < .001.
highly significantp < 0.0010.0× alphaqualifiedgold
When assessed as a group, the difference between PBMC and MMC CD4 + T cell percentage was highly significant after 1 y (57.9% ± 11.9% CD4 + PBMCs versus 34.6% ± 4.2% CD4 + MMCs; p < 0.001), 2 y (54.4% ± 10.9% CD4 + PBMCs versus 30.8% ± 9.8% CD4 + MMCs; p < 0.001), and 3 y (67.3% ± 9.8% CD4 + PBMCs versus 41.3% ± 4.9% CD4 + MMCs; p = 0.02) of suppressive antiviral therapy ( Figure 1 D).
highly significantp < 0.0010.0× alphaqualifiedgold
Five studies, 7 studies, 5 studies, 12 studies, 17 studies, 7 studies, and 2 studies were included to assess the effect of treatment on blood glucose levels at 1 week, 2 weeks, 3 weeks, 1 month, 2 months, 3 months, and 6 months, respectively, all of which showed a highly significant hypoglycemic effect in the MSC-treated group (1 week: SMD = − 1.484, 95%CI − 2.586 to − 0.381, p < 0.001; I 2 = 80.6%; 2 weeks: SMD = − 2.312, 95%CI − 3.743 to − 0.882, p = 0.002, I 2 = 89.6%; 3 weeks: SMD = − 4.007, 95%CI − 6.472 to − 1.541, p = 0.001, I 2 = 92.1%; 1 month: SMD = − 1.740, 95%CI − 2.660 to − 0.821, p < 0.001, I 2 = 83.8%; 2 months: SMD = − 1.830, 95%CI − 2.633 to − 1.028, p < 0.001; I 2 = 86.0%; 3 months: SMD = − 1.649, 95%CI − 2.838 to − 0.461, p = 0.007; I 2 = 84.6%; 6 months: SMD = − 3.045, 95%CI − 5.895 to − 0.195, p = 0.036; I 2 = 76.4%).